Canada markets closed

Pacira BioSciences, Inc. (PCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.21-0.11 (-0.40%)
At close: 04:00PM EDT
27.21 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.27B
Enterprise Value 1.57B
Trailing P/E 30.57
Forward P/E 9.89
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.10
Price/Book (mrq)1.45
Enterprise Value/Revenue 2.33
Enterprise Value/EBITDA 10.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 3-35.35%
S&P500 52-Week Change 322.38%
52 Week High 343.81
52 Week Low 325.33
50-Day Moving Average 328.48
200-Day Moving Average 331.12

Share Statistics

Avg Vol (3 month) 3483.46k
Avg Vol (10 day) 3410.19k
Shares Outstanding 546.52M
Implied Shares Outstanding 646.52M
Float 846M
% Held by Insiders 11.26%
% Held by Institutions 1108.15%
Shares Short (Apr 15, 2024) 43.45M
Short Ratio (Apr 15, 2024) 47.57
Short % of Float (Apr 15, 2024) 410.75%
Short % of Shares Outstanding (Apr 15, 2024) 47.41%
Shares Short (prior month Mar 15, 2024) 44.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 6.22%
Operating Margin (ttm)18.74%

Management Effectiveness

Return on Assets (ttm)3.35%
Return on Equity (ttm)5.10%

Income Statement

Revenue (ttm)674.98M
Revenue Per Share (ttm)14.60
Quarterly Revenue Growth (yoy)5.40%
Gross Profit (ttm)N/A
EBITDA 162.9M
Net Income Avi to Common (ttm)41.95M
Diluted EPS (ttm)0.89
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)278.58M
Total Cash Per Share (mrq)5.99
Total Debt (mrq)586.04M
Total Debt/Equity (mrq)67.35%
Current Ratio (mrq)5.24
Book Value Per Share (mrq)18.72

Cash Flow Statement

Operating Cash Flow (ttm)154.65M
Levered Free Cash Flow (ttm)107.15M